Axogen, Inc. — Director's Dealing 2025

Dec 17, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-12-16

Reporting Person: Weiler Kathy Johnson (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-12-16	Common Stock	M	18248	$7.04	Acquired	24828	Direct
2025-12-16	Common Stock	M	21825	$6.95	Acquired	46653	Direct
2025-12-16	Common Stock	S	18248	$29.547	Disposed	28405	Direct
2025-12-16	Common Stock	S	21825	$29.547	Disposed	6580	Direct
2025-12-16	Common Stock	S	6580	$29.55	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-16	Employee Stock Option (right to purchase)	$7.04	M	18248	Disposed	2034-06-06	Common Stock (18248)	Direct
2025-12-16	Employee Stock Option (right to purchase)	$6.95	M	21825	Disposed	2033-12-20	Common Stock (21825)	Direct

Footnotes

F1: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.01 to $30.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: Non-qualified stock option portion of the annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The grant fully vested on June 6, 2025, the one-year anniversary of the date of the grant.

F3: Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on December 20, 2024.